Ending Discrimination in COVID–19 Treatments Act

Summary

Ending Discrimination in COVID-19 Treatments Act This bill prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19. As a condition of receiving the therapies from the federal government, states must ensure that providers do not consider specified demographic characteristics, veteran status, or political ideology or speech when determining a patient's eligibility for such therapies.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 31 March 2022

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

   Source: IntroReferral

2. 31 March 2022

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 31 March 2022 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 31 March 2022

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 31 March 2022

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 31 March 2022

  Open at official source

Sponsors

• Ted Cruz · R · Sponsor
• · sshr00 · Standing

Related records

No cross-record relationships stored yet.